Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988 Categorization ( 42 CFR 493.17)
Extension without change of a currently approved collection
No
Regular
Approved without change
10/18/2010
08/23/2010
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
10/31/2013
36 Months From Approved
10/31/2010
900
0
900
900
0
900
46,800
0
0
A draft guidance titled Guidance for Administrative Procedures for CLIA Categorization was released for coment August 14,2000. The document describes procedures FDA will use to assign the complexity category to a device and includes information that manufacturers should send to FDA in cases where the complexity categorization is determined separate from the premarket submission.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.